Some types of decaffeinated coffee may acutely impair glucose metabolism but less than caffeine….
Read More »Earlier Screening for Diabetes Worthwhile
It’s currently recommended that people be screened for Type 2 diabetes starting at age 45, particularly if they are overweight. But a new study suggests that it would be worthwhile to start Type 2 diabetes screening earlier — between the ages of 30 and 45….
Read More »Tracking Blood Sugar with Nano-Tattoos
Chemical engineers are working on carbon nanotubes that could be injected under the skin to reveal blood glucose levels….
Read More »New and More Efficient Method to Make Insulin Cheaper
Researchers from the Helmholtz-Centre for Infection Research (HZI) in Braunschweig, Germany, have now developed a new method to cheaply produce insulin for the treatment of diabetes….
Read More »Using A1c to Define the Metabolic Syndrome
Using A1c instead of FPG to define MetS is feasible. It also identifies individuals with increased cardiovascular risk….
Read More »New Device Predicts Diabetic Wound Healing
A new breakthrough device developed by researchers can change the current landscape of chronic wound management…..
Read More »FDA Adds Risk for Severe Liver Injury to Orlistat Label
The US Food and Drug Administration (FDA) announced that it has revised the label for orlistat (Xenical) to include new safety information about rare cases of severe liver injury reported with the use of the weight-loss medication….
Read More »Type 2 Diabetes Increases Risk of 24 Cancers
Kari Hemminki in Sweden has carried out the largest study ever on cancer risks of people with Type 2 diabetes.…
Read More »Debate Rages on HbA1c for Diabetes Diagnosis
An international expert panel’s recommendation last year that glycated hemoglobin (HbA1c) should be the primary test for diagnosing Type 2 diabetes has met considerable resistance, with some researchers and clinicians insisting that the old standards remain the best….
Read More »Ranibizumab Reduces Vision Loss Due to Diabetes
Study shows around 40% of ranibizumab patients substantially improved vision by 10 letters or more on an eye-chart, compared to 16% with laser therapy alone….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.